The FDA approved desmopressin acetate (Desmoda) oral solution for the management of central diabetes insipidus in adults and ...
According to MarketsandMarketstm, the global pharmaceutical manufacturing equipment market is projected to reach USD 21.24 billion in 2026 and USD 30.39 billion by 2032, exhibiting a CAGR of 6.2% ...
According to MarketsandMarkets, the global pharmaceutical manufacturing equipment market is projected to reach USD 21.24 billion in 2026 and ...
The FDA has approved an oral liquid therapy for the treatment of central diabetes insipidus in people of all ages, according to a press release. Desmopressin acetate (Desmoda, Eton Pharmaceuticals) is ...
How integrated pharmaceutical manufacturing helps CDMOs simplify scale-up, reduce complexity, and move from raw materials to finished dosage forms faster.
Univar Solutions LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, today announced that its Ingredients + Specialties from ...
Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion's functional excipientsDOWNERS GROVE, Ill., Feb. 24, 2026 /PRNewswire/ ...
Piramal Pharma Solutions continues to lead its advanced dosage form expertise by successfully developing and commercializing a tablet-in-capsule product across its integrated drug product sites in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results